GPN 00884
Alternative Names: GPN-00884Latest Information Update: 03 Feb 2025
Price :
$50 *
At a glance
- Originator Grand Pharmaceutical Group
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Myopia